Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
doi: 10.1590/S0100-204X2006000100001 14
Research suggests BPC-157 modulates multiple pathways relevant to tissue repair, including VEGFR2-mediated angiogenesis, FAK-paxillin signaling in endothelial migration, Egr-1 transcription factor activity, and Akt/PI3K cellular survival signaling
At the molecular level, 5-amino-1MQ functions as a competitive inhibitor of NNMT, demonstrating remarkable potency with an IC of 1.2 0.1 M under standard assay conditions (50 M SAM, 100 M nicotinic acid). This represents a dramatic 10-fold improvement over the parent compound 1-methylquinolinium, achieved through strategic amino group substitution that enhances binding affinity to the NNMT active site. The compound's mechanism centers on preventing the methylation of nicotinamide to 1-methylnicotinamide (1-MNA), thereby preserving nicotinamide for recycling back to NAD+ through the salvage pathway. This intervention effectively blocks what researchers have termed the "NNMT metabolic drain" a process that simultaneously depletes NAD+ precursors and consumes cellular methylation capacity
It stands apart through its HPLC-certified 99% purity, providing the strict structural consistency needed for reliable, reproducible scientific research
US$ 23.80
US$ 26.24
US$ 20.35
US$ 24.71
US$ 28.04